Actively Recruiting
Exclusive Human-milk in Preterm NEOnates and Early VASCular Aging Risk Factors (NEOVASC)
Led by Prolacta Bioscience · Updated on 2025-08-29
200
Participants Needed
1
Research Sites
398 weeks
Total Duration
On this page
Sponsors
P
Prolacta Bioscience
Lead Sponsor
M
Medical University of Vienna
Collaborating Sponsor
AI-Summary
What this Trial Is About
Early vascular aging has its origins in fetal and neonatal life. The NEOVASC clinical trial aims to determine the effects of an exclusive human milk diet in extremely preterm infants on long-term cardiovascular health.
CONDITIONS
Official Title
Exclusive Human-milk in Preterm NEOnates and Early VASCular Aging Risk Factors (NEOVASC)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Extremely preterm infants with a birth weight of 500-1250g
- Feeding is NPO or exclusive human milk prior to enrollment
- Parent(s) willing to sign informed consent
- Term-born children with an adequate birth weight
- Parent(s) willing to sign informed consent
You will not qualify if you...
- Infants with a birth weight less than 500g or more than 1250g
- Diagnosed with inborn errors of metabolism such as galactosemia or phenylketonuria
- Not NPO or fed exclusive human milk diet prior to enrollment
- Presence of major congenital malformation
- Presence of intestinal perforation or Stage 2 Necrotizing enterocolitis prior to enrollment
- Parent(s) not willing to sign informed consent
- Unable to participate for any reason based on investigator's decision (e.g., unlikely to survive study period)
- Subjects with acute or chronic illness in the term-born group
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medical University of Innsbruck
Innsbruck, Tyrol, Austria, A-6020
Actively Recruiting
Research Team
U
Ursula Kiechl-Kohlendorfer, MD, MSc
CONTACT
W
Wolfgang Mitterer, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here